About Mabgenex
Mabgenex is a company based in Hyderabad (India) founded in 2018 by Suresh Chintalapati. It operates as a B2B. Mabgenex offers products and services including PrecinAb and OptinAb. Mabgenex operates in a competitive market with competitors including Benchsci, Antiverse, Nona Biosciences, EPITOPIC and Deep Biologics, among others.
- Headquarter Hyderabad, India
- Founders Suresh Chintalapati
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Mabgenex Private Limited
- Date of Incorporation 27 Dec, 2018
- Jurisdiction Hyderabad, Telangana, India
-
Annual Revenue
$307.67 (USD)0as on Mar 31, 2022
-
Net Profit
-$21.93 K (USD)-3902.06as on Mar 31, 2022
-
EBITDA
-$21.91 K (USD)-3924.02as on Mar 31, 2022
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Mabgenex
Mabgenex offers a comprehensive portfolio of products and services, including PrecinAb and OptinAb.
AI/ML assisted platform for discovering precision antibodies.
Cell surface display platform for optimized antibody development.
Funding Insights of Mabgenex
Detailed funding history for Mabgenex
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Mabgenex
Investment portfolio details for Mabgenex
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Mabgenex
Detailed financials for Mabgenex
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Mabgenex Comparisons
Peer comparison for Mabgenex
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Mabgenex
Mabgenex operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Benchsci, Antiverse, Nona Biosciences, EPITOPIC and Deep Biologics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
AI platform used for extracting antibody data from scientific papers.
|
|
| Locked | Locked | Locked |
An AI platform for antibody drug discovery is provided.
|
|
| Locked | Locked | Locked |
Offers antibody discovery, development, and engineering services for biotherapeutics.
|
|
| Locked | Locked | Locked |
Provider of cell therapy and antibody services
|
|
| Locked | Locked | Locked |
Provider of an AI-based antibody mining and screening platform for R&D work
|
|
| Locked | Locked | Locked |
Provides antibody prediction software for specialized applications.
|
Detailed competitors of Mabgenex
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Mabgenex
Complete news archive for Mabgenex
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mabgenex
Mabgenex was founded in 2018.
Mabgenex is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Suresh Chintalapati is the current CEO of Mabgenex. They have also founded this company.
Annual revenue of Mabgenex is $307.67 as on Mar 31, 2022.
mAbGenEx is a biotechnology company based in Hyderabad, India, focusing on antibody discovery and development. They combine traditional experimental methods with AI and ML to produce high-specificity antibodies for therapeutics in oncology and antivenom, as well as diagnostics for infectious diseases. Their platforms, PrecinAb and OptinAb, enable rapid innovation through in vitro and in silico approaches, collaborating with partners to advance healthcare solutions.
Mabgenex's top competitors include Antiverse, Benchsci and Deep Biologics.
Mabgenex offers PrecinAb and OptinAb.